Current evidence suggests facial Botox injections carry very low risk to a breastfed infant, with only trace amounts of botulinum toxin detected in breastmilk in recent sampling. Clinical bodies still advise caution rather than reassurance, so the responsible step is a frank conversation with your clinician before booking. Bring your breastfeeding status to that consultation and let it shape your plan.
TL;DR:
- A small facial dose study detected 34.4 to 167 pg/mL in milk, with peaks around day four and two months; infant outcome evidence remains limited.
- Moorfields advises a 24 to 48 hour discard window for some higher dose therapeutic injections, while cosmetic practice may differ.
- BOTOX product information says treatment is not recommended during breastfeeding, while LactMed reports no documented infant harm and considers milk transfer unlikely after cosmetic injections.
- Parents can continue feeding, express and discard milk for 24 to 48 hours, or delay treatment until weaning, depending on comfort and feeding routines.
- If choosing a discard period, store expressed milk beforehand and schedule injections after a feed; ask the clinician to document the product, dose, and sites.
Table of Contents
- What recent research found about Botox in breastmilk
- What authorities and specialist clinics advise
- If you decide to proceed: timing, expressing and questions to ask
- Study methods, time points and case reports: the technical view
- What a reputable clinic will do at consultation
- Balancing how you look with how you feed
- Booking a Botox consultation with breastfeeding in mind
- FAQ
- Sources
What recent research found about Botox in breastmilk
A study published on PubMed measured botulinum toxin type A in breastmilk following facial injections and found concentrations ranging from 34.4 to 167 pg/mL, with peaks appearing at around four days and again near two months after treatment. These figures come from women who had received cosmetic facial injections, not therapeutic doses for conditions such as spasticity or strabismus, which typically use far higher units.
To put those numbers into context, researchers converted the measured concentrations into an estimated infant oral dose. One calculation placed exposure at roughly 5 nanograms per kilogram per day, a figure that sits far below the doses used therapeutically when botulinum toxin is injected directly into children for medical conditions. That gap matters because therapeutic paediatric dosing is itself calculated with a wide safety margin, so trace oral exposure through milk falls well short of a level expected to cause measurable harm.
A key figure to hold onto: breastmilk concentrations of 34.4 to 167 pg/mL translate into an infant dose many times smaller than the toxin amounts given by injection for recognised paediatric treatments, which is why researchers describe the detected levels as unlikely to pose a measurable risk.
A few points temper how far this evidence can be stretched:
- The sample size in the detection study was small, so the findings describe a pattern rather than a population-wide guarantee.
- Every measurement came from facial cosmetic dosing; higher-dose therapeutic injections elsewhere in the body were not part of this dataset.
- Detection methods vary in sensitivity: ELISA testing picked up the low picogram-per-millilitre levels reported above, while some studies using LC-MS did not detect the toxin at all, which suggests the true transfer may sit near the lower limit of what current tools can measure.
These limitations do not undermine the headline finding so much as explain why clinical guidance remains careful rather than dismissive. A small study with sensitive detection methods is exactly the kind of evidence that supports a cautiously reassuring stance, not a blanket declaration of safety. The practical takeaway is that oral toxin exposure through milk, where it exists at all, appears to be a fraction of what would be needed to affect an infant, and that nuance is worth repeating to your clinician rather than assuming either extreme.
What authorities and specialist clinics advise
Several respected sources have weighed in on breastfeeding and botulinum toxin, and their positions cluster around the same cautious middle ground rather than a flat yes or no.
- The NCBI LactMed monograph on onabotulinumtoxinA states that the toxin is unlikely to enter breastmilk following cosmetic injection, noting that reported cases show either no detection or only minute amounts, with no documented infant harm.
- Moorfields Eye Hospital advises a cautious approach for patients receiving botulinum toxin for strabismus, and in some cases recommends expressing and discarding milk for 24 to 48 hours after injection as a conservative safety measure.
- The product information leaflet for BOTOX states that the treatment is not recommended during breastfeeding and advises discussing use with a healthcare professional before proceeding.
- NHS guidance on medicines and breastfeeding encourages open discussion with a GP or health visitor about any medicine or cosmetic procedure, and stresses choosing a regulated, reputable practitioner for cosmetic treatments.
It is worth noticing the difference in tone between a hospital protocol built for therapeutic, higher-dose injections and the guidance aimed at cosmetic facial treatment. Moorfields’ express-and-discard advice reflects a clinical setting where botulinum toxin is used at doses well beyond cosmetic ranges, which naturally leans more conservative. Many practitioners treating cosmetic patients, by contrast, accept continued breastfeeding after a full discussion and documented consent, precisely because the measured transfer at cosmetic doses is so small.
The common thread across LactMed, Moorfields, the manufacturer’s own leaflet and NHS advice is not a prohibition. It is a consistent instruction to talk to a qualified professional, disclose that you are breastfeeding, and let that conversation, rather than a blanket rule, decide your path.
If you decide to proceed: timing, expressing and questions to ask
Once you have evidence in hand, the decision becomes practical rather than purely medical. Three broad options exist, and which one suits you depends on your comfort with the data and your feeding routine.
- Proceed with no interruption to feeding. Many clinicians support this given the low measured transfer described above, particularly for standard facial dosing.
- Express and discard for 24 to 48 hours. This mirrors the conservative approach some hospital settings use and suits parents who want an extra margin of reassurance.
- Delay treatment until partial or full weaning. This removes the question entirely and works well if your booking is not time-sensitive.
If you choose to express and discard, plan ahead: express enough milk before your appointment to cover feeds during the discard window, store it safely in the fridge or freezer for later use, and keep a clean pump routine throughout. Scheduling your appointment shortly after a feed, rather than before one, also gives you more flexibility if you decide on a short precautionary gap.
Bring a short list of questions to your consultation so nothing gets missed in the moment:
Pro Tip: Ask your practitioner to confirm the total dose and injection sites in writing, along with how they would expect any systemic spread to behave, so you leave with a clear record rather than a verbal summary.
Useful points to raise include the exact product and dose being used, which areas will be treated, how the practitioner monitors for any unexpected reaction afterwards, and what aftercare signs would prompt you to call the clinic. A clinician who welcomes these questions and documents your breastfeeding status as part of consent is doing exactly what current guidance expects.
Study methods, time points and case reports: the technical view
For readers who want the detail behind the headline figures, the design of the detection study matters. Facial injections were given at a cosmetic dose, and breastmilk samples were drawn at multiple time points afterwards rather than just once, which is how researchers caught two separate peaks, one around day four and another near the two-month mark. That dual-peak pattern suggests a slow, low-level release rather than a single sharp spike, though the mechanism behind the later peak is not fully explained in the available data.
Detection method matters as much as timing:
- ELISA testing, which is highly sensitive to very small protein quantities, picked up the 34.4 to 167 pg/mL range reported in the facial injection study.
- Some separate investigations using LC-MS, a technique with different sensitivity characteristics, failed to detect the toxin at all in comparable samples, which points to transfer levels sitting right at the edge of what current assays can reliably confirm.
- Western blot methods, used in some older case work, add a further layer of variability in reported sensitivity, which is part of why figures across studies are not perfectly consistent.
Beyond the facial injection study, older case reports covering accidental or therapeutic botulinum toxin exposure in breastfeeding mothers, summarised in reviews referenced by NCBI, describe instances where mothers continued breastfeeding without observed harm to the infant. These cases are not a cosmetic dosing dataset, but they reinforce the broader pattern: when toxin has been present in a breastfeeding mother’s system, documented infant illness has been rare to absent in the available literature.
None of this closes every gap. The no-observed-effect level for infant oral exposure to botulinum toxin through milk has not been firmly established, sample sizes across the relevant studies remain small, and direct testing of infant outcomes after maternal cosmetic Botox is limited rather than extensive. Botulism itself, as public health bodies such as the World Health Organization note, is rare but serious, which is part of why researchers and clinicians alike prefer a careful, evidence-led tone over either reassurance or alarm.
What a reputable clinic will do at consultation
A well-run consultation treats your breastfeeding status as clinical information, not small talk. At The Aesthetics Room, we are CQC-registered and hold ACE Group membership, both of which require documented safety and consent processes for every patient.
Expect a consultation that includes:
- A full medical history review, including current breastfeeding status and feeding frequency.
- An open discussion of the evidence above, so you understand the reasoning behind whatever plan you choose.
- Tailored dosing and injection site planning based on your individual anatomy and goals.
- Written, documented consent that records the breastfeeding conversation alongside standard treatment consent.
- Clear aftercare instructions, including what to watch for and who to contact with concerns.
If you decide an expressing window suits you better, a good clinic will help you plan appointment timing around your feeding schedule rather than leaving you to work it out alone.
Balancing how you look with how you feed
Wanting to feel like yourself again after having a baby is not vanity, it is common, and the evidence available so far supports a measured, not fearful, response to Botox while breastfeeding, alongside exploring options like photobiomodulation benefits for wellness. What matters more than any single statistic is whether you have had a proper conversation with a qualified clinician who takes your feeding status seriously. Let that discussion, not guesswork, guide your timing.
— Vishul
Booking a Botox consultation with breastfeeding in mind
We treat breastfeeding status as a standard part of every Botox consultation, not an afterthought, and this conversation gets documented alongside your consent.
When you book with us, you can expect:
- A full discussion of the evidence above, tailored to your individual history and feeding routine.
- Transparent pricing, with Anti Wrinkle treatment ranging from £200 to £358 depending on the areas treated.
- Flexible appointment scheduling if you prefer to coordinate treatment around an expressing window.
Visit our Botox treatment page to see practitioner details and book a consultation, or check our full price list before you come in.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
How long can I breastfeed after Botox?
Many clinicians support continuing to breastfeed without interruption after facial Botox, given the low transfer levels measured in recent research. Some parents choose to express and discard milk for 24 to 48 hours as an extra precaution, a practice drawn from Moorfields’ guidance for therapeutic injections, though this is not universally required for cosmetic doses.
How long does Botox stay in your system while breastfeeding?
Breastmilk sampling found detectable botulinum toxin at two separate points, around four days and again near two months after facial injection, at concentrations between 34.4 and 167 pg/mL. This pattern suggests a slow, low-level presence rather than a single short-lived spike, though research into the exact clearance timeline is still limited.
Can I get Botox while breastfeeding?
The manufacturer’s product information leaflet for BOTOX states it is not recommended during breastfeeding and advises discussing it with a healthcare professional, while LactMed notes that transfer into milk is unlikely to be significant at cosmetic doses. A qualified clinician can walk you through this guidance and help you decide what fits your situation.
How soon after you stop breastfeeding can you get Botox?
There is no fixed waiting period specified in current clinical guidance once breastfeeding has fully stopped, since the caution around treatment relates specifically to possible transfer through milk. Once weaning is complete, the usual pre-treatment consultation and medical history review apply as they would for any other patient.
Sources
- Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk
- OnabotulinumtoxinA — NCBI/LactMed summary
- Botulinum toxin injections for strabismus during pregnancy and breastfeeding — Moorfields
- Breastfeeding and medicines — NHS
